Abrdn PLC Fulcrum Therapeutics, Inc. Transaction History

Abrdn PLC

$57.3 Billion
Q2 2025

A detailed history of Abrdn PLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Abrdn PLC holds 58,696 shares of FULC stock, worth $401,480. This represents 0.0% of its overall portfolio holdings.

Number of Shares

58,696

Holding current value

$401,480

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Jul 24, 2025	BUY	$2.51 - $7.38 $147,326 - $433,176	58,696 New	58,696 $403,000
Q4 2023 Jan 31, 2024	BUY	$3.18 - $6.86 $816,903 - $1.76 Million	256,888 New	256,888 $1.73 Million

Others Institutions Holding FULC

# of Institutions

123

Shares Held

52M

Call Options Held

48.9K

Put Options Held

13.8K

Ra Capital Management, L.P. Boston, MA

10.2M
Shares

$70 Million
0.61% of portfolio
Tcg Crossover Management, LLC Palo Alto, CA

5.25M
Shares

$35.9 Million
3.64% of portfolio
Suvretta Capital Management, LLC New York, NY

5.07M
Shares

$34.7 Million
0.64% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

4.82M
Shares

$33 Million
0.63% of portfolio
Black Rock Inc. New York, NY

4.8M
Shares

$32.8 Million
0.0% of portfolio

View Full List

About Fulcrum Therapeutics, Inc.

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $356M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

More about FULC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account